Pieter Sonneveld

Research interests

Publications

• Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

  New England Journal of Medicine · 2023 · 10.1056/nejmoa2312054

• Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2020.11.014

• Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

  Leukemia · 2020 · 10.1038/s41375-020-0876-z

• Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)31240-1

• Multiple myeloma

  Nature Reviews Disease Primers · 2017 · https://doi.org/10.1038/nrdp.2017.46

• Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx096

• Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

  Blood · 2016 · 10.1182/blood-2016-01-631200

• International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

  The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)30206-6

• Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

  New England Journal of Medicine · 2016 · 10.1056/nejmoa1606038

• Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

  Journal of Clinical Oncology · 2015 · 10.1200/jco.2015.61.2267

• European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

  Haematologica · 2015 · 10.3324/haematol.2014.117176

• Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

  Blood · 2015 · 10.1182/blood-2014-12-615187

• Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

  The Lancet Oncology · 2013 · 10.1016/s1470-2045(13)70380-2

• IMWG consensus on risk stratification in multiple myeloma

  Leukemia · 2013 · 10.1038/leu.2013.247

• Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

  Journal of Clinical Oncology · 2012 · 10.1200/jco.2011.39.6820

• Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

  Leukemia · 2011 · 10.1038/leu.2011.196

• Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

  Leukemia · 2010 · 10.1038/leu.2010.60

• High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

  New England Journal of Medicine · 2009 · 10.1056/nejmoa0901409

• International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

  Leukemia · 2008 · 10.1038/leu.2008.307

• Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression

  Journal of Clinical Oncology · 2007 · 10.1200/jco.2006.10.5460

• Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

  Leukemia · 2007 · 10.1038/sj.leu.2405062

• International uniform response criteria for multiple myeloma

  Leukemia · 2006 · https://doi.org/10.1038/sj.leu.2404284

• Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa043445

• International Staging System for Multiple Myeloma

  Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.04.242

• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

  New England Journal of Medicine · 1995 · https://doi.org/10.1056/nejm199512073332305

Current projects

No projects listed.